The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Predictors of Nursing Home Placement in Parkinson's Disease: A Population‐Based, Prospective Study
Abstract
OBJECTIVES : To examine the rate and predictors of nursing home placement in patients with Parkinson's disease. DESIGN : Four‐year prospective study. SETTING : A population‐based study in western Norway PARTICIPANTS : 178 community‐dwelling subjects with Parkinson's disease. MEASUREMENTS : Main outcome measure was the time from baseline to nursing home admission. Baseline evaluation of motor symptoms (Unified Parkinson's Disease Rating Scale, UPDRS), cognition (clinical dementia interview, Gottfries, Bråne & Steen dementia scale, and Mini‐Mental State Examination), depression (clinical interview and the Montgomery & Åsberg Depression Rating Scale), and psychotic symptoms (UPDRS Thought Disorder item) were performed. RESULTS : Forty‐seven patients (26.4%) were admitted to a nursing home during the 4‐year study period. Institutionalized patients were older, had more advanced Parkinson's disease with more severe motor symptoms and impairment of activities of daily living, were cognitively more impaired, were more often living alone, and had more hallucinations than those who continued to live at home. Duration of disease, levodopa dose, and gender distribution did not differ between the two groups. A Cox proportional hazards linear regression analysis showed that old age, functional impairment, dementia, and hallucinations were independent predictors of nursing home admission. CONCLUSIONS : Both motor and neuropsychiatric symptoms contributed to institutionalization, but the presence of hallucinations was the strongest predictor. This finding indicates it is possible that effective treatment of hallucinations may reduce the need for institutionalization in patients with Parkinson's disease. J Am Geriatr Soc 48:938–942, 2000 .
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Parkinson disease (PD) is progressive, with dementia and medication-refractory motor problems common reasons for late-stage nursing-home placement.”
From Does vigorous exercise have a neuroprotective effect in Parkinson disease? (2011) · cites this paper as [1]
Citations
Cites
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282
A new depression scale designed to be sensitive to change
Montgomery, S. A., & Åsberg, M. (1979) · British Journal of Psychiatry · doi:10.1192/bjp.134.4.382 · Cited by 13,962
Parkinsonism: onset, progression, and mortality
Hoehn, M. M., & Yahr, M. D. (1967) · Neurology · doi:10.1212/wnl.17.5.427 · Cited by 12,107
Low-Dose Clozapine for the Treatment of Drug-Induced Psychosis in Parkinson's Disease
The Parkinson Study Group (1999) · New England Journal of Medicine · doi:10.1056/nejm199903113401003 · Cited by 618
Mental symptoms in Parkinson's disease are important contributors to caregiver distress
Aarsland, D., Larsen, J. P., Karlsen, K., Lim, N. G., & Tandberg, E. (1999) · International Journal of Geriatric Psychiatry · doi:10.1002/(sici)1099-1166(199910)14:10 · Cited by 484
Self-citationRisk factors for nursing home placement in advanced Parkinson's disease
Goetz, C. G., & Stebbins, G. T. (1993) · Neurology · doi:10.1212/wnl.43.11.2227 · Cited by 460
A prospective study of long-term care institutionalization among the aged.
Branch, L. G., & Jette, A. M. (1982) · American Journal of Public Health · doi:10.2105/ajph.72.12.1373 · Cited by 440
The Occurrence of Depression in Parkinson's Disease
Tandberg, E. (1996) · Archives of Neurology · doi:10.1001/archneur.1996.00550020087019 · Cited by 413
Self-citationPredictors of Institutionalization Among Caregivers of Patients With Alzheimer's Disease
Colerick, E. J., & George, L. K. (1986) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1986.tb04239.x · Cited by 393
Prevalence and Clinical Correlates of Psychotic Symptoms in Parkinson Disease
Aarsland, D., Larsen, J. P., Cummings, J. L., & Laake, K. (1999) · Archives of Neurology · doi:10.1001/archneur.56.5.595 · Cited by 347
Self-citation
Research works printed but not linked: 2
- Fahn S, 1987, Recent Development in Parkinson's Disease, 153
- 1987, Diagnostic and Statistical Manual of Mental Disorders
Cited by
Sorted by citations
Clinical diagnostic criteria for dementia associated with Parkinson’s disease
Emre, M., Aarsland, D., Brown, R., Burn, D. J., Duyckaerts, C., Mizuno, Y., Broe, G. A., Cummings, J., Dickson, D. W., Gauthier, S., et al. (2007) · Movement Disorders · doi:10.1002/mds.21507 · Cited by 3,027
Self-citationNon-motor symptoms of Parkinson's disease: diagnosis and management
Chaudhuri, K. R., Healy, D. G., & Schapira, A. H. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(06)70373-8 · Cited by 2,807
A systematic review of prevalence studies of dementia in Parkinson's disease
Aarsland, D., ZACCAI, J. H., & Brayne, C. (2005) · Movement Disorders · doi:10.1002/mds.20527 · Cited by 1,714
Self-citationBalestrino, R., & Schapira, A. H. V. (2020) · European Journal of Neurology · doi:10.1111/ene.14108 · Cited by 1,508
Barone, P., Antonini, A., Colosimo, C., Marconi, R., Morgante, L., Avarello, T. P., Bottacchi, E., Cannas, A., Ceravolo, G., Ceravolo, R., et al. (2009) · Movement Disorders · doi:10.1002/mds.22643 · Cited by 1,445
Parkinson disease-associated cognitive impairment
Aarsland, D., Batzu, L., Halliday, G. M., Geurtsen, G. J., Ballard, C. G., Chaudhuri, К. R., & Weintraub, D. A. (2021) · Nature Reviews Disease Primers · doi:10.1038/s41572-021-00280-3 · Cited by 1,540
Self-citationPrevalence and Characteristics of Dementia in Parkinson Disease
Aarsland, D., Andersen, K., Larsen, J. O., & Lolk, A. (2003) · Archives of Neurology · doi:10.1001/archneur.60.3.387 · Cited by 1,403
Self-citationChaudhuri, K. R., Martinez‐Martin, P., Schapira, A. H. V., Stocchi, F., Sethi, K., Odin, P., Brown, R. G., Koller, W., Barone, P., MacPhee, G., et al. (2006) · Movement Disorders · doi:10.1002/mds.20844 · Cited by 1,100
The distinct cognitive syndromes of Parkinson's disease: 5 year follow-up of the CamPaIGN cohort
Williams‐Gray, C. H., Evans, J., Goris, A., Foltynie, T., Ban, M., Robbins, T. W., Brayne, C., Kolachana, B. S., Weinberger, D. R., Sawcer, S. J., et al. (2009) · Brain · doi:10.1093/brain/awp245 · Cited by 1,017
Dalrymple‐Alford, J. C., MacAskill, M. R., Nakas, C. T., Livingston, L., Graham, C., Crucian, G. P., Melzer, T. R., Kirwan, J. P., Keenan, R., Wells, S. R., et al. (2010) · Neurology · doi:10.1212/wnl.0b013e3181fc29c9 · Cited by 965
Evolution of cognitive dysfunction in an incident Parkinson's disease cohort
Williams‐Gray, C. H., Foltynie, T., Brayne, C., Robbins, T. W., & Barker, R. (2007) · Brain · doi:10.1093/brain/awm111 · Cited by 935
Kehagia, A. A., Barker, R. A., & Robbins, T. W. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70212-x · Cited by 928
MDS task force on mild cognitive impairment in Parkinson's disease: Critical review of PD‐MCI
Litvan, I., Aarsland, D., Adler, C. H., Goldman, J. G., Kulisevsky, J., Mollenhauer, B., Rodríguez‐Oroz, M., Tröster, A. I., & Weintraub, D. A. (2011) · Movement Disorders · doi:10.1002/mds.23823 · Cited by 811
Self-citationRisk of dementia in Parkinson’s disease: A community-based, prospective study
Aarsland, D., Andersen, K., Larsen, J. P., Lolk, A., Nielsen, H., & Kragh–Sørensen, P. (2001) · Neurology · doi:10.1212/wnl.56.6.730 · Cited by 721
Self-citationSubtypes of mild cognitive impairment in parkinson's disease: Progression to dementia
Janvin, C. C., Larsen, J. P., Aarsland, D., & Hugdahl, K. (2006) · Movement Disorders · doi:10.1002/mds.20974 · Cited by 592
Self-citationNeuropsychiatric symptoms in Parkinson's disease
Aarsland, D., Marsh, L., & Schrag, A. (2009) · Movement Disorders · doi:10.1002/mds.22589 · Cited by 320
Self-citationMartínez‐Martín, P., Schapira, A. H. V., Stocchi, F., Sethi, K. D., Odin, P., Macphee, G. J. A., Brown, R. G., Naidu, Y., Clayton, L. M. S., Abe, K., et al. (2007) · Movement Disorders · doi:10.1002/mds.21586 · Cited by 556
Diagnostic criteria for psychosis in Parkinson's disease: Report of an NINDS, NIMH work group
Ravina, B., Marder, K., Fernandez, H. H., Friedman, J. H., McDonald, W., Murphy, D., Aarsland, D., Babcock, D., Cummings, J., Endicott, J., et al. (2007) · Movement Disorders · doi:10.1002/mds.21382 · Cited by 528
Self-citationAarsland, D., Brønnick, K., Ehrt, U., Deyn, P. P. D., Tekin, S., Emre, M., & Cummings, J. L. (2006) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2005.083113 · Cited by 519
Self-citationDoes vigorous exercise have a neuroprotective effect in Parkinson disease?
Ahlskog, J. E. (2011) · Neurology · doi:10.1212/wnl.0b013e318225ab66 · Cited by 463
Changes in motor subtype and risk for incident dementia in Parkinson's disease
Alves, G. W., Larsen, J. P., Emre, M., Wentzel‐Larsen, T., & Aarsland, D. (2006) · Movement Disorders · doi:10.1002/mds.20897 · Cited by 434
Self-citationParkinson’s disease dementia: a neural networks perspective
Gratwicke, J., Jahanshahi, M., & Foltynie, T. (2015) · Brain · doi:10.1093/brain/awv104 · Cited by 459
The retina in Parkinson's disease
Archibald, N. K., Clarke, M. W., Mosimann, U. P., & Burn, D. J. (2009) · Brain · doi:10.1093/brain/awp068 · Cited by 408
A 12-Year Population-Based Study of Psychosis in Parkinson Disease
Forsaa, E. B., Larsen, J. P., Wentzel‐Larsen, T., Goetz, C. G., Stebbins, G. T., Aarsland, D., & Alves, G. W. (2010) · Archives of Neurology · doi:10.1001/archneurol.2010.166 · Cited by 400
Self-citationHealth‐related quality of life in early Parkinson's disease: The impact of nonmotor symptoms
Duncan, G. W., Khoo, T. K., Yarnall, A. J., O'Brien, J. T., Coleman, S. Y., Brooks, D. J., Barker, R. A., & Burn, D. J. (2013) · Movement Disorders · doi:10.1002/mds.25664 · Cited by 383
Epidemiology of Parkinson’s disease
Alves, G. W., Forsaa, E. B., Pedersen, K. F., Gjerstad, M. D., & Larsen, J. P. (2008) · Journal of Neurology · doi:10.1007/s00415-008-5004-3 · Cited by 405
Self-citationA pathophysiological model of freezing of gait in Parkinson's disease
Lewis, S. J. G., & Barker, R. A. (2008) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2008.08.006 · Cited by 343
Donepezil for cognitive impairment in Parkinson's disease: a randomised controlled study
Aarsland, D. (2002) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.72.6.708 · Cited by 341
Self-citationParkinson's disease is associated with hippocampal atrophy
Camicioli, R. M., Moore, M. M., Kinney, A. E. “., Corbridge, E., Glassberg, K., & Kaye, J. A. (2003) · Movement Disorders · doi:10.1002/mds.10444 · Cited by 337
Marsh, L., McDonald, W. M., Cummings, J. L., Ravina, B. M., & NINDS/NIMH Work Group on Depression and Parkinson's Disease (2005) · Movement Disorders · doi:10.1002/mds.20723 · Cited by 319
Hallucinations in Parkinson disease
Diederich, N. J., Fénelon, G., Stebbins, G., & Goetz, C. G. (2009) · Nature Reviews Neurology · doi:10.1038/nrneurol.2009.62 · Cited by 312
Burn, D. J., Emre, M., McKeith, I. G., Deyn, P. P. D., Aarsland, D., Hsu, C., & Lane, R. M. (2006) · Movement Disorders · doi:10.1002/mds.21077 · Cited by 310
Self-citationVisual dysfunction in Parkinson disease without dementia
Uc, E. Y., Rizzo, M., Anderson, S. W., Qian, S., Rodnitzky, R. L., & Dawson, J. D. (2005) · Neurology · doi:10.1212/01.wnl.0000191565.11065.11 · Cited by 308
The impact of depressive symptoms in early Parkinson disease
Ravina, B. M., Camicioli, R. M., Como, P. G., Marsh, L., Jankovic, J. J., Weintraub, D. A., & Elm, J. J. (2007) · Neurology · doi:10.1212/01.wnl.0000268695.63392.10 · Cited by 301
Diederich, N. J., Goetz, C. G., & Stebbins, G. T. (2004) · Movement Disorders · doi:10.1002/mds.20308 · Cited by 290
The Rate of Cognitive Decline in Parkinson Disease
Aarsland, D., Andersen, K., Larsen, J. P., Perry, R., Wentzel‐Larsen, T., Lolk, A., & Kragh-Sørensen, P. (2004) · Archives of Neurology · doi:10.1001/archneur.61.12.1906 · Cited by 282
Self-citationEpidemiology of psychosis in Parkinson's disease
Fénelon, G., & Alves, G. (2010) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2009.08.014 · Cited by 330
Weintraub, D. A., Oehlberg, K. A., Katz, I. R., & Stern, M. B. (2006) · American Journal of Geriatric Psychiatry · doi:10.1097/01.jgp.0000192488.66049.4b · Cited by 279
Cognitive dysfunction and dementia in Parkinson?s disease
Bosboom, J. L. W., Stoffers, D., & Wolters, E. C. (2004) · Journal of Neural Transmission · doi:10.1007/s00702-004-0168-1 · Cited by 274
Clinical phenotype of Parkinson disease dementia
Galvin, J. E., Pollack, J., & Morris, J. C. (2006) · Neurology · doi:10.1212/01.wnl.0000242630.52203.8f · Cited by 264
Atomoxetine for depression and other neuropsychiatric symptoms in Parkinson disease
Weintraub, D., Mavandadi, S., Mamikonyan, E., Siderowf, A. D., Duda, J. E., Hurtig, H. I., Colcher, A., Horn, S. S., Nazem, S., Ten Have, T. R., et al. (2010) · Neurology · doi:10.1212/wnl.0b013e3181ebdd79 · Cited by 255
Rabey, J. M., Prokhorov, T., Miniovitz, A., Dobronevsky, E., & Klein, C. (2006) · Movement Disorders · doi:10.1002/mds.21116 · Cited by 259
Coelho, M. M., & Ferreira, J. J. (2012) · Nature Reviews Neurology · doi:10.1038/nrneurol.2012.126 · Cited by 250
The non-motor symptom complex of Parkinson’s disease: A comprehensive assessment is essential
Chaudhuri, К. R., Yates, L. R., & Martínez‐Martín, P. (2005) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-005-0072-6 · Cited by 252
Cognitive dysfunction and dementia in Parkinson disease
Caballol, N. S., Martı́, M. J., & TOLOSA, E. S. (2007) · Movement Disorders · doi:10.1002/mds.21677 · Cited by 242
The clinical heterogeneity of Parkinson's disease and its therapeutic implications
Greenland, J. C., Williams‐Gray, C. H., & Barker, R. A. (2018) · European Journal of Neuroscience · doi:10.1111/ejn.14094 · Cited by 239
Parkinson's disease dementia: Definitions, guidelines, and research perspectives in diagnosis
Goetz, C. G., Emre, M., & Dubois, B. (2009) · Annals of Neurology · doi:10.1002/ana.21455 · Cited by 232
Stahl, S. M. (2016) · CNS Spectrums · doi:10.1017/s1092852916000407 · Cited by 222
Cognitive, psychiatric and motor response to galantamine in Parkinson's disease with dementia
Aarsland, D., Hutchinson, M., & Larsen, J. P. (2003) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.949 · Cited by 219
Self-citationTherapies in Parkinsonʼs disease
Jankovic, J. J., & Poewe, W. H. (2012) · Current Opinion in Neurology · doi:10.1097/wco.0b013e3283542fc2 · Cited by 223
Pathophysiology and Treatment of Psychosis in Parkinson’s Disease
Zahodne, L. B., & Fernandez, H. H. (2008) · Drugs & Aging · doi:10.2165/00002512-200825080-00004 · Cited by 211
Combined effect of age and severity on the risk of dementia in Parkinson's disease
Levy, G., Schupf, N., Tang, M., COTE, L. J., Louis, E. D., Mejia‐Santana, H., Stern, Y., & Marder, K. S. (2002) · Annals of Neurology · doi:10.1002/ana.10219 · Cited by 209
GBA Variants are associated with a distinct pattern of cognitive deficits in P arkinson's disease
Mata, I. F., Leverenz, J. B., Weintraub, D. A., Trojanowski, J. Q., Chen‐Plotkin, A. S., Deerlin, V. M. V., Ritz, B. R., Rausch, R., Factor, S. A., Wood‐Siverio, C., et al. (2015) · Movement Disorders · doi:10.1002/mds.26359 · Cited by 210
Visual symptoms in Parkinson's disease and Parkinson's disease dementia
Archibald, N. K., Clarke, M. P., Mosimann, U. P., & Burn, D. J. (2011) · Movement Disorders · doi:10.1002/mds.23891 · Cited by 220
APOE,MAPT, andSNCAGenes and Cognitive Performance in Parkinson Disease
Mata, I. F., Leverenz, J. B., Weintraub, D. A., Trojanowski, J. Q., Hurtig, H. I., Deerlin, V. M. V., Ritz, B. R., Rausch, R., Rhodes, S. L., Factor, S. A., et al. (2014) · JAMA Neurology · doi:10.1001/jamaneurol.2014.1455 · Cited by 203
Neuropsychiatric Symptoms of Patients With Progressive Supranuclear Palsy and Parkinson's Disease
Aarsland, D., Litvan, I., & Larsen, J. O. (2001) · Journal of Neuropsychiatry · doi:10.1176/jnp.13.1.42 · Cited by 207
Self-citationPsychiatric aspects of Parkinson?s disease: An Update
Schrag, A. (2004) · Journal of Neurology · doi:10.1007/s00415-004-0483-3 · Cited by 200
Greenberg, S. A. (2007) · AJN American Journal of Nursing · doi:10.1097/01.naj.0000292204.52313.f3 · Cited by 196
Amboni, M., Tessitore, A., Esposito, F., Santangelo, G., Picillo, M., Vitale, C., Giordano, A., Erro, R., Micco, R. D., Corbo, D., et al. (2014) · Journal of Neurology · doi:10.1007/s00415-014-7591-5 · Cited by 201
Scales to assess psychosis in Parkinson's disease: Critique and recommendations
Fernandez, H. H., Aarsland, D., Fénelon, G., Friedman, J. H., Marsh, L., Tröster, A. I., Poewe, W. H., Rascol, O., Sampaio, C., Stebbins, G. T., et al. (2008) · Movement Disorders · doi:10.1002/mds.21875 · Cited by 188
Self-citationProdromal frontal/executive dysfunction predicts incident dementia in Parkinson's disease
Woods, S. P., & Tröster, A. I. (2003) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617703910022 · Cited by 191
Progression of motor symptoms in Parkinson’s disease
Xia, R., & Mao, Z. (2012) · Neuroscience Bulletin · doi:10.1007/s12264-012-1050-z · Cited by 186
Compta, Y., Martı́, M. J., Ibarretxe‐Bilbao, N., Junqué, C., Valldeoriola, F., Muñoz, E., Ezquerra, M., Ríos, J., & TOLOSA, E. S. (2009) · Movement Disorders · doi:10.1002/mds.22594 · Cited by 185
Profile of Cognitive Impairment in Parkinson's Disease
Watson, G. S., & Leverenz, J. B. (2010) · Brain Pathology · doi:10.1111/j.1750-3639.2010.00373.x · Cited by 203
Dorsey, E. R., Deuel, L. M., Voss, T., Finnigan, K. S., George, B. P., Eason, S., Miller, D. W., Reminick, J. I., Appler, A., Polanowicz, J., et al. (2010) · Movement Disorders · doi:10.1002/mds.23145 · Cited by 188
Janvin, C. C., Aarsland, D., & Larsen, J. P. (2005) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/0891988705277540 · Cited by 182
Self-citationLate-Life Psychosis: Diagnosis and Treatment
Reinhardt, M. M., & Cohen, C. I. (2015) · Current Psychiatry Reports · doi:10.1007/s11920-014-0542-0 · Cited by 184
Williams‐Gray, C. H., Hampshire, A., Robbins, T. W., Owen, A. M., & Barker, R. A. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.0774-07.2007 · Cited by 181
Prefrontal dopamine signaling and cognitive symptoms of Parkinson’s disease
Narayanan, N. S., Rodnitzky, R. L., & Uc, E. Y. (2013) · Reviews in the Neurosciences · doi:10.1515/revneuro-2013-0004 · Cited by 181
Levodopa unresponsive symptoms in Parkinson disease
Sethi, K. D. (2008) · Movement Disorders · doi:10.1002/mds.22049 · Cited by 177
Hermanowicz, S., & Hermanowicz, N. S. (2016) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2016.1158102 · Cited by 173
Meireles, J., & Massano, J. (2012) · Frontiers in Neurology · doi:10.3389/fneur.2012.00088 · Cited by 181
Emergency hospital admissions in idiopathic Parkinson's disease
Woodford, H. J., & Walker, R. W. (2005) · Movement Disorders · doi:10.1002/mds.20485 · Cited by 170
Dorsey, E. R., George, B. P., Leff, B. A., & Willis, A. W. (2013) · Neurology · doi:10.1212/wnl.0b013e318293e2ce · Cited by 168
The challenge of non-motor symptoms in Parkinson’s disease
Chaudhuri, К. R., & Odin, P. (2010) · Progress in brain research · doi:10.1016/s0079-6123(10)84017-8 · Cited by 164
Blind randomized controlled study of the efficacy of cognitive training in Parkinson's disease
Prats, A., Saleta, H. G., Crespo, M. C., Silvestre, E., Garolera, M., Torrellas, C. P., Pont, S. A., Nadal, M. F., Garcia, S. A., Bartolomé, M. V. P., et al. (2011) · Movement Disorders · doi:10.1002/mds.23688 · Cited by 174
The Neuropsychiatry of Parkinson Disease: A Perfect Storm
Weintraub, D. A., & Mamikonyan, E. (2019) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2019.03.002 · Cited by 172
The effect of age of onset of PD on risk of dementia
Aarsland, D., Kvaløy, J. T., Andersen, K., Larsen, J. P., Tang, M. X., Lolk, A., Kragh-Sørensen, P., & Marder, K. (2007) · Journal of Neurology · doi:10.1007/s00415-006-0234-8 · Cited by 162
Self-citationThe Malignant Course of “Benign Hallucinations” in Parkinson Disease
Goetz, C. G., Fan, W., Leurgans, S. E., Bernard, B. A., & Stebbins, G. T. (2006) · Archives of Neurology · doi:10.1001/archneur.63.5.713 · Cited by 161
How common are complications of Parkinson's disease?
Schrag, A. E., Ben‐Shlomo, Y., & Quinn, N. P. (2002) · Journal of Neurology · doi:10.1007/s004150200032 · Cited by 159
Rater-blinded, Prospective Comparison
Merims, D., Balas, M., Peretz, C., Shabtai, H., & Giladi, N. (2006) · Clinical Neuropharmacology · doi:10.1097/01.wnf.0000236769.31279.19 · Cited by 156
Mild cognitive impairment in Parkinson's disease.
Goldman, J. G., & Litvan, I. (2011) · PubMed · Cited by 152
Goldman, J. G., Stebbins, G. T., Dinh, V., Bernard, B. A., Merkitch, D., deToledo‐Morrell, L., & Goetz, C. G. (2014) · Brain · doi:10.1093/brain/awt360 · Cited by 155
Psychiatric Complications in Parkinson Disease
Weintraub, D. A., & Stern, M. B. (2005) · American Journal of Geriatric Psychiatry · doi:10.1176/appi.ajgp.13.10.844 · Cited by 149
Cognitive impairment in Parkinson's disease and dementia with Lewy bodies
Aarsland, D. (2015) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2015.09.034 · Cited by 145
Self-citationPredictors of nursing home placement in Huntington disease
Wheelock, V., Tempkin, T., Marder, K. S., NANCE, M. A., Myers, R. H., Zhao, H., Kayson, E., Orme, C., Shoulson, I., & the Huntington Study Group (2003) · Neurology · doi:10.1212/01.wnl.0000052992.58107.67 · Cited by 145
The economic impact of cognitive impairment in Parkinson's disease
Vossius, C., Larsen, J. O., Janvin, C. C., & Aarsland, D. (2011) · Movement Disorders · doi:10.1002/mds.23661 · Cited by 142
Self-citationDementia Risk in Parkinson Disease
Setó‐Salvia, N., Clarimón, J., Pagonabarraga, J., Pascual‐Sedano, B., Campolongo, A., Combarros, O., Mateo, J. I., Regaña, D., Martínez-Corral, M., Marquié, M., et al. (2011) · Archives of Neurology · doi:10.1001/archneurol.2011.17 · Cited by 145
Trial of pimavanserin in dementia-related psychosis
Tariot, P. N., Cummings, J. L., Soto-Martin, M. E., Ballard, C., Erten-Lyons, D., Sultzer, D. L., Devanand, D. P., Weintraub, D., McEvoy, B., Youakim, J. M., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2034634 · Cited by 145
The spectrum of cognitive impairment in Lewy body diseases
Goldman, J. G., Williams‐Gray, C. H., Barker, R. A., Duda, J. E., & Galvin, J. E. (2014) · Movement Disorders · doi:10.1002/mds.25866 · Cited by 146
Bilateral Deep Brain Stimulation of the Nucleus Basalis of Meynert for Parkinson Disease Dementia
Gratwicke, J., Zrinzo, L. U., Kahan, J., Peters, A., Beigi, M., Akram, H., Hyam, J. A., Oswal, A., Day, B. L., Mancini, L., et al. (2017) · JAMA Neurology · doi:10.1001/jamaneurol.2017.3762 · Cited by 141
A randomized controlled trial of quetiapine for psychosis in Parkinson’s disease
Shotbolt, P. (2009) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s5335 · Cited by 140
Frucht, S. J. (2004) · The Neurologist · doi:10.1097/01.nrl.0000131146.08278.a5 · Cited by 139
Silveira, C. R. A., MacKinley, J. D., Coleman, K. K. L., Li, Z., Finger, E. C., Bartha, R., Morrow, S. A., Wells, J., BORRIE, M. J., Tirona, R. G., et al. (2019) · BMC Neurology · doi:10.1186/s12883-019-1252-3 · Cited by 138
Friedman, J. H., Berman, R., Goetz, C. G., Factor, S. A., Ondo, W. G., Wojcieszek, J., Carson, W. H., & Marcus, R. N. (2006) · Movement Disorders · doi:10.1002/mds.21091 · Cited by 138
Predictors of weight loss in Parkinson's disease
Uc, E. Y., Struck, L. K., Rodnitzky, R. L., Zimmerman, B. M., Dobson, J., & Evans, W. J. (2006) · Movement Disorders · doi:10.1002/mds.20837 · Cited by 137
The Treatment of Sleep Disorders in Parkinson’s Disease: From Research to Clinical Practice
Loddo, G., Buonaura, G. C., Sambati, L., Giannini, G., Cecere, A., Cortelli, P., & Provini, F. (2017) · Frontiers in Neurology · doi:10.3389/fneur.2017.00042 · Cited by 143
A semi‐structured interview to assess visual hallucinations in older people
Mosimann, U. P., Collerton, D., Dudley, R. E. J., Meyer, T. D., Graham, G., Dean, J. L., Bearn, D., Killen, A., Dickinson, L., Clarke, M. P., et al. (2008) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.1965 · Cited by 135
Excessive Daytime Sleepiness in Patients with Parkinsonʼs Disease
Knie, B., Mitra, M. T., Logishetty, K., & Chaudhuri, K. R. (2011) · CNS Drugs · doi:10.2165/11539720-000000000-00000 · Cited by 132
Cognitive training interventions for dementia and mild cognitive impairment in Parkinson’s disease
Orgeta, V., McDonald, K. R., Poliakoff, E., Hindle, J. V., Clare, L., & Leroi, I. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011961.pub2 · Cited by 144
Metadata
- Authors
- Aarsland, D., Larsen, J. P., Tandberg, E., & Laake, K.
- Affiliations
- Stavanger University Hospital (NO)
- Oslo University Hospital (NO)
- Corresponding author
- Aarsland, Dag
- ORCID
- Aarsland, Dag
- Venue
- Journal of the American Geriatrics Society
- Publisher
- Wiley
- Published
- 2000-08
- Volume
- 48
- Issue
- 8
- Pages
- 938-942
- ISSN
- 0002-8614 (ISSN-L)
- 1532-5415
- OpenAlex
- W2083220625
- Cited by
- 811
- References
- 21
- Citations by year
- 2026: 15 · 2025: 30 · 2024: 30 · 2023: 33 · 2022: 33 · 2021: 42 · 2020: 64 · 2019: 36 · 2018: 35 · 2017: 36 · 2016: 37 · 2015: 32 · 2014: 42 · 2013: 42 · 2012: 33
- FWCI
- 7.66
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of the American Geriatrics Society (publishedVersion)
- PubMed (publishedVersion)
- Journal of the American Geriatrics Society
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Health Sciences › Medicine › Geriatrics and Gerontology › Geriatric Care and Nursing Homes
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- Parkinson's disease, nursing home admission, institutionalization, predictors of institutionalization, hallucinations, dementia, functional disability, activities of daily living, motor symptoms, neuropsychiatric symptoms, depression, community-dwelling patients
- MeSH terms
- Activities of Daily Living, Adult, Aged, Aged, 80 and over, Dementia, Female, Hallucinations, Humans, Male, Middle Aged, Norway, Nursing Homes, Parkinson Disease, Patient Admission, Predictive Value of Tests, Prospective Studies, Psychiatric Status Rating Scales, Risk Factors, Severity of Illness Index, Geriatric Assessment, Linear Models, Proportional Hazards Models, Age Distribution, Community Health Planning
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
